The Evolving Treatment Paradigm of Hepatocellular Carcinoma: An Expert Case-based Discussion - Episode 13

Patient Profile 3: Advanced HCC Treated With Cabozantinib in Second Line

, , , ,

Centering discussion on the final patient profile, panelists consider how they select optimal therapy in the second-line setting of advanced hepatocellular carcinoma.